Drawing for HEPARREV

USPTO serial 99930269

HEPARREV

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
JOHNSON, DANYTHE ELIZABETH HA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEPARREV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Guiping Liang

5F, West Building, Julong Complex,No.9 Hangda Rd., Xihu Dist.,Hangzhou, 310007

Goods and services

ClassDescriptionStatusFirst use
005Plant extracts for pharmaceutical purposes; Vitamin preparations; Food for babies; Nutritional supplements; Nutraceuticals for use as a dietary supplement; Yeast dietary supplements; Dietary supplements for animals; Folic acid dietary supplements; Protein supplements; Wheat germ dietary supplements; Dietetic supplements adapted for medical purposes; Dietary fiber for use as a dietary supplement; Medicinal herbal extracts for medical purposes; Lactose for medical purposes; Crystallized rock sugar for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026DOCKASSIGNED TO EXAMINER—
Jul 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance